Bausch Health Companies Inc.
Income Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Revenue | $820.4M | $757.2M |
| Cost of Revenue | $204.3M | $197.2M |
| Gross Profit | $616.1M | $560.0M |
| Gross Margin | 75.1% | 74.0% |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $167.6M | $188.9M |
| Operating Income | $181.2M | $124.1M |
| Operating Margin | 22.1% | 16.4% |
| Interest Expense | — | — |
| Pretax Income | $175.0M | — |
| Income Tax Expense | $-1.5M | $-73.0M |
| Net Income | $406.6M | $199.9M |
| Net Margin | 49.6% | 26.4% |
| EPS (Basic) | $1.11 | $1.25 |
| EPS (Diluted) | $1.11 | $1.25 |
| Shares Outstanding (Basic) | 158.2M | 159.7M |
| Shares Outstanding (Diluted) | 158.5M | 159.7M |
| Dividends Per Share | $0.65 | $1.50 |